Outcomes4Me
PrivateLast Round
Series A
May 29, 2025
Total Funding Raised
$37.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Outcomes4Me is a healthtech company that provides an AI-driven, direct-to-patient platform for cancer care, offering personalized treatment options, clinical trial matching, and symptom management.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Clinical Trials, Healthcare Analytics, Precision Medicine
Business Model
B2B2C
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Outcomes4Me Comparables
Compare Outcomes4Me with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Belong.Life | 81% | |
| Jasper Health | 78% | |
| OncoPower | 77% |
Outcomes4Me Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 29, 2025 | ||||
| Series A | Apr 28, 2021 | ||||
| Seed | Nov 18, 2020 |
Outcomes4Me Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Seed |
| Sierra Ventures | Series A, Seed |
| Salica Investments | Series A |
| Salica Investments | Series A |
| Asset Management Ventures | Series A, Seed |
| Northpond Ventures | Series A |
| Hambro Perks Ltd. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 60% MoM.
- Oct 10, 2025
Launched a cancer-focused app incorporating NCCN guidelines.
Recent news
Latest coverage and updates
- recognized_asSep 14, 2026
For the second year in a row, Outcomes4Me Inc. is honored on the Inc. 5000 list of fastest-growing private companies after experiencing 395% three-year growth.
- hiresSep 14, 2026
Outcomes4Me Inc. hires Jim Longley as Chief Revenue Officer to lead its revenue organization and expand life sciences collaborations in Massachusetts on Sep 14th '26.
- hiresSep 14, 2026
Outcomes4Me Inc. appoints Jim Longley as Chief Revenue Officer on Sep 14th '26 in Massachusetts, where he leads the commercial team and revenue organization to support growth and expand life sciences collaborations.
- recognized_asSep 14, 2026
The prestigious Prix Galien USA program recognizes Outcomes4Me Inc. as a nominee for “Best Startup.”.
- recognized_asSep 14, 2026
TIME names Outcomes4Me Inc. to its Best Inventions of 2025, while Fast Company recognizes it as a World Changing Idea.
Outcomes4Me Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Outcomes4Me's valuation, stock price, and market status.
Is Outcomes4Me a public or private company?
Outcomes4Me is a private company.
What is the current stock price of Outcomes4Me?
Outcomes4Me is a private company, so its shares have no public market price. Caplight tracks Outcomes4Me's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Outcomes4Me worth (valuation)?
Valuation information for Outcomes4Me is not publicly available.
Can I buy Outcomes4Me stock?
Outcomes4Me shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Outcomes4Me's last funding round?
Outcomes4Me's most recent funding round was Series A on May 29, 2025.
Who are the main investors in Outcomes4Me?
Key investors in Outcomes4Me include Salica Investments, Salica Investments, Asset Management Ventures, Northpond Ventures, Hambro Perks Ltd..
Will Outcomes4Me IPO soon?
No public IPO plans have been announced for Outcomes4Me.
How can I track Outcomes4Me secondary market activity?
Caplight tracks bids, offers, and trades in Outcomes4Me's shares on secondary markets.